Physician profile
John Larson
NPI 1215932173
$739.26
in general payments reported to CMS, 2019-2025
17 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $275 · 2020: $28.40 · 2021: $49.13 · 2022: $91.86 · 2023: $71.37 · 2024: $69.71 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $114.24 | 2019 | |
| Kerecis Limited | $109.48 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Smith+Nephew, INC. | $97.31 | 2019-2025 | Collagenase Santyl |
| Organogenesis INC. | $74.47 | 2019-2022 | |
| Integra Lifesciences Corporation | $63.16 | 2019-2020 | |
| Derma Sciences, INC. | $39.36 | 2019 | |
| Solventum Corporation | $37.14 | 2024-2025 | Activ.A.C., Promogran Prisma |
| Supernus Pharmaceuticals, INC. | $29.95 | 2023-2025 | Qelbree, Qelbree |
| Stryker Corporation | $25.76 | 2024 | Actishield |
| Janssen Pharmaceuticals, INC | $24.89 | 2019-2022 | |
| Sanofi Pasteur INC. | $24.73 | 2023 | |
| Bsn Medical INC | $23.35 | 2024 | |
| Xeris Pharmaceuticals, INC. | $17.97 | 2021 | |
| Kci USA, INC. | $17.05 | 2023 | Snap, Activ.A.C. |
| Takeda Pharmaceuticals U.S.A., INC. | $14.18 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.88 | 2022 | |
| Abbvie INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Larson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.